Search by Drug Name or NDC

NDC 70934-0809-87 Ondansetron 8 mg/1 Details

Ondansetron 8 mg/1

Ondansetron is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The primary component is ONDANSETRON.

MedlinePlus Drug Summary

Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.

Related Packages: 70934-0809-87
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ondansetron

Product Information

NDC	70934-0809
Product ID	70934-809_c9c4f96d-386f-1a9b-e053-2995a90ab6b2
Associated GPIs	50250065007240
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Ondansetron
Proprietary Name Suffix	n/a
Non-Proprietary Name	Ondansetron
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, ORALLY DISINTEGRATING
Route	ORAL
Active Ingredient Strength	8
Active Ingredient Units	mg/1
Substance Name	ONDANSETRON
Labeler Name	Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Pharmaceutical Class	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA090469
Listing Certified Through	n/a

Package

NDC 70934-0809-87 (70934080987)

Pricing Information	N/A
NDC Package Code	70934-809-87
Billing NDC	70934080987
Package	6 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-809-87)
Marketing Start Date	2021-04-22
NDC Exclude Flag	N